EurekAlert!: Possible treatment breakthrough for the rare disease arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic right ventricular cardiomyopathy type 5 (ARVC5) is a fatal genetic disease for which there is unfortunately no cure. Now, scientists at the Centro Nacional de Investigaciones ... Arrhythmogenic right ventricular dysplasia, or ARVD โ€” also known as arrhythmogenic right ventricular cardiomyopathy, or ARVC โ€” is a genetic condition (autosomal dominant) affecting the desmosomes of ...

Understanding the Context

News Medical: Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy A new study in mice shows that replacement of a dysfunctional gene could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy (ARVC), a rare inherited disorder in which ... Gene therapy could prolong survival in some people with arrhythmogenic right ventricular cardiomyopathy Arrhythmogenic Right Ventricular Cardiomyopathy (ARVC) is an inheritable myocardial disorder characterised by the progressive replacement of cardiac muscle with fibrofatty tissue. This structural ... Arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C) is challenging to diagnose because of nonspecific findings, particularly in the early phases of the disease.

Key Insights

Clinical diagnosis is ... Arrhythmogenic right ventricular dysplasia/cardiomyopathy was first reported as the partial replacement of the right ventricular myocardium by fat or fibrous tissue. In 1965, researchers described the ...